PGS: Pre-Implantation Genetic Testing (Embryo) - 6

Preimplantation Genetic Screening (PGS) Embryo 6 assesses all 24 chromosome pairs in embryos created through in vitro fertilization (IVF) to detect chromosomal abnormalities before implantation.

This test is recommended for:

• Couples with recurrent pregnancy loss.
• Women undergoing IVF at an advanced maternal age (>35 years).
• Individuals with a history of chromosomal abnormalities.
• Couples with unexplained infertility.

A few cells are biopsied from the embryo at the blastocyst stage, and next-generation sequencing (NGS) or array comparative genomic hybridization (aCGH) is used to analyze the chromosomal makeup.

• Euploid Embryos: Normal chromosomal count, increasing the chance of a successful pregnancy.
• Aneuploid Embryos: Abnormal chromosomal count, which may lead to failed implantation or miscarriage.

PGS enhances the likelihood of successful implantation and a healthy pregnancy by selecting chromosomally normal embryos for transfer.